Challenge
This pharmaceutical manufacturer of both sterile and non-sterile products was required to respond to three separate observations from the FDA.

Solution
Developed and organized over 200 issues into major categories to strategically implement solutions for on-going compliance initiatives.

Benefits
By responding quickly to the FDA's observations, this company:

		Improved its relationship with regulatory agencies
		Reestablished its reputation with customers for high-quality manu- facturing standards

Download full PDF